AUG 27, 2019 12:44 PM PDT

A Skin Patch Might be the Most Effective Melanoma Treatment

WRITTEN BY: Tiffany Dazet

Researchers from the Massachusetts Institute of Technology (MIT) have developed a fast-acting skin patch that effectively delivers cancer-fighting medication to affected melanoma cells. Their research was presented yesterday at the American Chemical Society (ACS) Fall 2019 Meeting and Exposition. The entire presentation is in the video below.

A skin patch is ideal for melanoma treatment because traditional treatments are not fully effective or convenient. Medicated ointments don’t penetrate skin layers deeply enough, and although syringes deliver medicine efficiently, they’re painful and inconvenient for patient-use.

Microneedle patches are a painless and successful way to deliver treatment. They’re prepared with a layer-by-layer (LbL) coating methods, which covers surfaces with molecules of alternative positive and negative charges. Previous LbL methods created a very sticky film, causing the medication delivery time to last 15 to 90 minutes. Researchers feared that this long application time would lead to non-compliance by patients.

The team from MIT, led by Paula T. Hammond, Ph.D. and her graduate students Yanpu He and Celestine Hong, solved the problem of the prior microneedle patches by designing a new pH-responsive polymer. When tested in mice, this microneedle treatment produced nine times the antibody level compared to intramuscular injections and 160 times the antibody level compared to subcutaneous injections. They saw similar results when testing surgical samples of human skin.

In a statement from ACS, Yanpu He stated: “Our patch has a unique chemical coating and mode of action that allows it to be applied and removed from the skin in just a minute while still delivering a therapeutic dose of drugs. Our patches elicit a robust antibody response in living mice and show promise in eliciting a strong immune response in human skin.”

Hammond and her team are excited for the patch’s use by oncologists to fight melanoma, in addition to its use in fighting infectious diseases. Hammond told ACS reporters that, “We are using low-cost chemistry and a simple fabrication scheme to transform vaccination. Ultimately, we want to get a device approved and on the market.”

Sources: ACS, ACS Nano

About the Author
  • Tiffany grew up in Southern California, where she attended San Diego State University. She graduated with a degree in Biology with a marine emphasis, thanks to her love of the ocean and wildlife. With 13 years of science writing under her belt, she now works as a freelance writer in the Pacific Northwest.
You May Also Like
APR 25, 2020
Cancer
APR 25, 2020
Breaking the Blood-Brain Barrier in the Fight Against Brain Cancer
One of the more unique aspects of the human body is the blood-brain barrier (BBB) that protects the central nervous syst ...
MAY 04, 2020
Cancer
MAY 04, 2020
A Retroactive Study Finds an Immunotherapy Effective as a Third-Line Therapy
Cancer is a particularly persistent disease. Many therapies are composed of one or more different treatments. These trea ...
MAY 07, 2020
Genetics & Genomics
MAY 07, 2020
Will the Next Outbreak Come From Cattle?
Many species of Campylobacter bacteria are infectious and can cause a disease called campylobacteriosis in animals and p ...
MAY 11, 2020
Cell & Molecular Biology
MAY 11, 2020
3D Cell Culture Model Suggests Herpes Can Cause Alzheimer's
Alzheimer's is a common form of dementia that affects as many as 5.5 million Americans and the incidence is increasing a ...
MAY 13, 2020
Microbiology
MAY 13, 2020
Low Vitamin D Levels Linked to COVID-19 Mortality
The COVID-19 pandemic has swept through various countries with widely discrepant mortality rates.
MAY 19, 2020
Clinical & Molecular DX
MAY 19, 2020
Hormone Levels in Infants Linked to Autism
  A potential biomarker for autism has been identified in infants: the levels of a hormone called vasopressin found ...
Loading Comments...